The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows

scientific article

The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JBIOMECH.2008.03.021
P698PubMed publication ID18571181
P5875ResearchGate publication ID5283642

P50authorPaolo DecuzziQ42666172
P2093author name stringX Liu
M Ferrari
D Fine
F Gentile
C Chiappini
M Ming-Cheng Cheng
M S Peluccio
R C Bhavane
P433issue10
P304page(s)2312-2318
P577publication date2008-06-20
P1433published inJournal of BiomechanicsQ4862281
P1476titleThe effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows
P478volume41

Reverse relations

cites work (P2860)
Q90609307A mathematical model to predict nanomedicine pharmacokinetics and tumor delivery
Q49618396Active targeted delivery of immune therapeutics to lymph nodes
Q93184904Advances in nanocarriers as drug delivery systems in Chagas disease
Q33679533An integrated approach for the rational design of nanovectors for biomedical imaging and therapy
Q39030222Antibody-drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment.
Q37436787Bacteriophage Associated Silicon Particles: Design and Characterization of a Novel Theranostic Vector with Improved Payload Carrying Potential
Q34213499Biodistribution and clearance of a filamentous plant virus in healthy and tumor-bearing mice
Q37531135Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice
Q39005226Cancer nanomedicine: progress, challenges and opportunities
Q97074379Cell Membrane-Based Biomimetic Nanoparticles and the Immune System: Immunomodulatory Interactions to Therapeutic Applications
Q42658959Cell and nanoparticle transport in tumour microvasculature: the role of size, shape and surface functionality of nanoparticles.
Q39031369Cell-Based Biohybrid Drug Delivery Systems: The Best of the Synthetic and Natural Worlds
Q34030709Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects
Q57377620Delivery of thrombolytic therapy using rod-shaped plant viral nanoparticles decreases the risk of hemorrhage
Q36236848Design considerations for nanotherapeutics in oncology
Q38122098Design rules for nanomedical engineering: from physical virology to the applications of virus-based materials in medicine
Q34349709Development of functional biomaterials with micro- and nanoscale technologies for tissue engineering and drug delivery applications
Q42117781Direct Tracking of Particles and Quantification of Margination in Blood Flow.
Q39491847E-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrow
Q46483867Elastic particle deformation in rectangular channel flow as a measure of particle stiffness
Q37109774Ellipsoidal Polyaspartamide Polymersomes with Enhanced Cell-Targeting Ability
Q40053619Elongated plant virus-based nanoparticles for enhanced delivery of thrombolytic therapies
Q36892538Emergence and Utility of Nonspherical Particles in Biomedicine
Q94596645Emerging Prospects for Nanoparticle-Enabled Cancer Immunotherapy
Q33917755Enabling individualized therapy through nanotechnology
Q37205125Engineering nano- and microparticles to tune immunity
Q41978913Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks
Q56902291Formation of Polymeric Nanocubes by Self-Assembly and Crystallization of Dithiolane-Containing Triblock Copolymers
Q47822397Formation of Polymeric Nanocubes by Self-Assembly and Crystallization of Dithiolane-Containing Triblock Copolymers.
Q38645312From a silane monomer to anisotropic buckled silica nanospheres: a polymer-mediated, solvent-free and one-pot synthesis
Q33746335Frontiers in cancer nanomedicine: directing mass transport through biological barriers
Q58602364Imaging breast cancer using a dual-ligand nanochain particle
Q36366404Imaging metastasis using an integrin-targeting chain-shaped nanoparticle
Q30527772Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle Potato virus X.
Q60142299Influence of particle size and shape on their margination and wall-adhesion: implications in drug delivery vehicle design across nano-to-micro scale
Q33824885Internalization of red blood cell-mimicking hydrogel capsules with pH-triggered shape responses
Q47147470Magnetic Sensing Potential of Fe3O4 Nanocubes Exceeds That of Fe3O4 Nanospheres
Q55130996Manipulating nanoparticle transport within blood flow through external forces: an exemplar of mechanics in nanomedicine.
Q47730496Margination and adhesion of micro- and nanoparticles in the coronary circulation: a step towards optimised drug carrier design.
Q30577405Margination of micro- and nano-particles in blood flow and its effect on drug delivery
Q50453339Microparticle shape effects on margination, near-wall dynamics and adhesion in a three-dimensional simulation of red blood cell suspension.
Q34166491Multi-stage delivery nano-particle systems for therapeutic applications
Q37609544Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications
Q39673726Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs.
Q38802375Nanomedicines for renal disease: current status and future applications
Q48044023Nanoparticle elasticity directs tumor uptake
Q39173710Nanoparticle transport and delivery in a heterogeneous pulmonary vasculature
Q50226473Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics
Q57069049New opportunities for nanoparticles in cancer immunotherapy
Q36703526Non-affinity factors modulating vascular targeting of nano- and microcarriers
Q38261278Non-spherical micro- and nanoparticles: fabrication, characterization and drug delivery applications.
Q37896558Novel platforms for vascular carriers with controlled geometry
Q30540909On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better.
Q65556502Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles
Q26829530Particle margination and its implications on intravenous anticancer drug delivery
Q49628457Particle morphology: an important factor affecting drug delivery by nanocarriers into solid tumors.
Q38047267Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking
Q34579964Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries
Q39410383Post-nano strategies for drug delivery: Multistage porous silicon microvectors
Q37162182Principles of nanoparticle design for overcoming biological barriers to drug delivery
Q90254628Rapid Electrostatic Capture of Rod-Shaped Particles on Planar Surfaces: Standing up to Shear
Q55350285Reconstituted high-density lipoproteins: novel biomimetic nanocarriers for drug delivery.
Q38573793Role of particle size, shape, and stiffness in design of intravascular drug delivery systems: insights from computations, experiments, and nature
Q97424921Sequential deconstruction of composite drug transport in metastatic breast cancer
Q35801327Shape Control in Engineering of Polymeric Nanoparticles for Therapeutic Delivery.
Q37298480Shape matters: the diffusion rates of TMV rods and CPMV icosahedrons in a spheroid model of extracellular matrix are distinct
Q51602330Shape-mediated margination and demargination in flowing multicomponent suspensions of deformable capsules.
Q37829181Shape-specific polymeric nanomedicine: emerging opportunities and challenges
Q36204756Shaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging
Q33755231Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles
Q37184228Silicon micro- and nanofabrication for medicine
Q64229646Small, Smaller, Nano: New Applications for Potato Virus X in Nanotechnology
Q27334548Stealth filaments: Polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X.
Q38968910Strategies for improving drug delivery: nanocarriers and microenvironmental priming
Q48179204Surface modification and cellular uptake evaluation of Au-coated Ni80Fe20 nanodiscs for biomedical applications
Q47589446Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications
Q35858739Synthetic Strategies for Engineering Intravenous Hemostats
Q30496003Tailored porous silicon microparticles: fabrication and properties.
Q27010317Targeted nanotechnology for cancer imaging
Q37068238The Impact of Aspect Ratio on the Biodistribution and Tumor Homing of Rigid Soft-Matter Nanorods
Q57150723The Shape Effect on Polymer Nanoparticle Transport in a Blood Vessel
Q36488910The effects of particle size, density and shape on margination of nanoparticles in microcirculation
Q38847912The effects of particle size, shape, density and flow characteristics on particle margination to vascular walls in cardiovascular diseases
Q91722969The platelet shape change: biophysical basis and physiological consequences
Q38062890The role of particle geometry and mechanics in the biological domain
Q54400009Titanium dioxide nanoparticle-induced oxidative stress triggers DNA damage and hepatic injury in mice.
Q35967955To Target or Not to Target: Active vs. Passive Tumor Homing of Filamentous Nanoparticles Based on Potato virus X
Q39804161Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agents
Q35251878Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle
Q37415867Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle.
Q34398830USNCTAM perspectives on mechanics in medicine.
Q27026630Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm
Q90298628Vascular-targeted particle binding efficacy in the presence of rigid red blood cells: Implications for performance in diseased blood
Q28550482Virus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicine

Search more.